Diabetes type 2 Flashcards

1
Q

what is T2 diabetes

A

A condition in which the combination of insulin resistance and beta-cell failure result in hyperglycaemia
Associated with obesity but not always
The resultant chronic hyperglycaemia may initially be managed by changes to diet / weight loss and may even be reversible
With time glucose lowering therapy including insulin, is needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which things causes T2 diabetes

A

Genetics + obesity leading to insulin resistance –> relative insulin deficiency –> hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when does T2 diabetes present and what is it’s key feature

A

T2DM may present in youth / young adults
Diabetic ketoacidosis can be a feature of T2DM
Note T2 can develop in youth as well as in later life

Autoimmune diabetes leading to insulin deficiency can present later in life = latent autoimmune diabetes in adults (LADA)
Monogenic diabetes can present phenotypically as Type 1 or Type 2 diabetes (eg. MODY, mitochondrial diabetes)
Diabetes may present following pancreatic damage or other endocrine disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the epidemiology of T2

A

Prevalence of T2DM varies enormously
Increasing prevalence
Occurring and being diagnosed younger
Greatest in ethnic groups that move from rural to urban lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the stages of development of T2

A

1) Normal
fasting glucose <= 6 mmol/L
2 h glucose ( OGTT) <7.7 mmol/L
HbA1c <43 mmol/mol

2) intermediate stage
impaired fasting glucose
impaired glucose tolerance
prediabetes / non diabetic hyperglycaemia

3) T2 diabetes
fasting glucose =>7 mmol/L
2 h glucose ( OGTT) / random glucose >=11 mmol/L
HbA1c >=48 mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How to diagnose T2

A

Random glucose of >11,1 with symptoms of diabetes

Note beta cells function declines with T2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is meant by relative insulin deficiency in T2

A

Insulin is produced by pancreatic beta-cells but not enough to overcome insulin resistance
There is therefore a relative deficiency of insulin
This is important to understand as it explains why the hyperglycaemia encountered does not cause ketosis under ‘usual’ circumstances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why does Beta cell function decline with T2

A

In long-duration type 2 diabetes, beta-cell failure may progress to complete insulin deficiency
Usually on insulin at this point in any case, but important not to stop as at risk of ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are teh causes if T2

A

Genes and intrauterine environment and adult environment.
Insulin resistance and insulin secretion defects
Fatty acids important in pathogenesis and complications

HETEROGENOUS
People develop T2D at variable BMI, ages and progress differently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how does T2 responded to glucose of Insulin

A

1) high plasma glucose

2) no response to insulin when more is added

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is first phase insulin release and why it it lost in T2

A

Previously mentioned that in response to a meal, stored insulin is released and more is produced.

People with T2DM or those who are about to develop diabetes do not have this stored insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does T2 diabetes do to skeletal muscle adn liver function

A

In type 2 diabetes, reduced insulin action causes less uptake of glucose into skeletal muscle
Hepatic glucose production is also increased due to both a reduction in insulin action and increase in glucagon action

these 2 things cause hyperglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why do ppl with T2 diabetes have high blood sugar

A

Decreased Glucose Disposal and Increased HGP Contribute to Increased FPG in T2DM
This slide illustrates how impaired glucose disposal and increased hepatic glucose production (HGP) contribute to increased fasting plasma glucose (FPG) in type 2 diabetes mellitus (T2DM).
The diminished ability to store or oxidize glucose in muscle due to impaired insulin activity reduces the metabolic clearance rate of glucose (top graph), and an excessive amount of glucose is converted to lactate.1 Lactate then returns to the liver to be metabolized back to glucose (Cori cycling). The early increase in FPG in the progression to T2DM is often a result of Cori cycling from the previous night’s meal.
Inadequate insulin action also causes an increased flux of substrates – glycerol and free fatty acids – to the liver, resulting in increased gluconeogenesis.
Inappropriate glucagon secretion induces continued glucose production by stimulating glycogenolysis (release of glucose from glycogen, its stored form) and gluconeogenesis (glucose synthesis) (bottom graph).
Thus, at the liver, impaired insulin-mediated glucose disposal and excessive glucagon-mediated glucose output have the combined effect of increasing FPG in T2DM.
In people with T2DM with FPG levels <140 mg/dL, fasting HGP is less evident, whereas inefficient glucose utilization and inadequate suppression of glucagon following meals lead to abnormal Cori cycling. In those with FPG >140 mg/dL, fasting HGP is increased, further exacerbating the problem.
A dashed yellow line marks the American Diabetes Association’s diagnostic criterion of 126 mg/dL for FPG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what happens to insulin sensitivity in T2

A

Is lost so increasing conc of insulin won’t help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the consequences of insulin resistance

A

See

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What cytokines are increased in T2 and why

A

Excess of inflammatory adipokines:
TNF-alpha IL-6: Stimulates lipolysis and VLDL secretion ↑ IR whole body and muscle ↓ adiponectin expression
Endocannabinoids: Insulin inhibits expression in fat Fat IR> ↑ Circulating EC
Leptin: Elevated in obesity ↑ IR whole body muscle and liver ↓ Appetite ↑ Metabolic rate
Resistin: Elevated in obesity and T2DM ↑ IR whole body and liver ↑ Liver TG secretion
Glucocorticoids: ↑ 11-B HSB-I in fat ↑ Fat cell size and IR ↑ Glucose BP lipids
Adiponectin: ↓ Insulin resistance Predicative of diabetes
Fatty acids: Elevated in obesity and T2DM ↑ IR whole body muscle and liver ↓ B cell function ↑ Liver TG secretion ↑ Organ fat, oxidative stress
Apelin: Insulin stimulates expression in fat Elevated in hyperinsulin Cardiovascular effects
Visfatin: Visceral fat ↓ IR whole body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the 2 types of genetic mutation that can causes T2

A

1) Single gene mutation ==> Diabetes (MODY)
‘Born with it, always going to develop diabetes’

2)Polymorphisms increasing risk of diabetes
‘Not born with it but high risk and may develop later depending on other factors’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is ment by polygenic

A

T2 diabetes is caused by multiple gene mutations –> the mores of these genes you have the more likely it is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

extra

A

extra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

extra

A

extra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

extra

A

extra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

extra

A

extra

23
Q

extra

A

eztea

24
Q

what is the link between obesity and T2

A
Major risk factor for T2DM
Fatty acids and adipocytokines important
Central vs visceral obesity
80% T2DM are obese
Weight reduction useful treatment
25
Q

what are other factors that can be linked with T2

A

1) Perturbations in gut microbiota
Obesity, insulin resistance T2DM
Bacterial lipopolysaccharides fermentation to short chain FA, bacterial modulation bile acids
Inflammation, signaling metabolic pathways
Most studies correlative

2) Intra-uterine growth retardation
Hales et al 1991
Weight at age 1 year <8.16kg, 22% had type 2 diabetes of IGT
Weight age 1 year >12.25 kg, 6% had type 2 diabetes or IGT

26
Q

What is the presentation of T2

A
Hyperglycaemia
Overweight
Dyslipidaemia
Fewer osmotic symptoms
With complications
Insulin resistance
Later insulin deficiency
27
Q

What are risk factors for T2

A

Risk factors:
Age PCOS
BMI Family Hx
Ethnicity Inactivity

28
Q

How do you diagnose T2

A

Osmotic symptoms
Infections
Screening test: incidental finding
at presentation of complication
Acute; hyperosmolar hyperglycaemic state,
Chronic; ischaemic heart disease, retinopathy

First line test for diagnosis is HbA1c.

1x HbA1c >=48mmol/L with symptoms

Or

2x HbA1c >=48 mmol/mol if aysymptomatic

29
Q

what is the hyperosmolar hyperglycaemic state

A

Presents commonly with renal failure.
Insufficient insulin (NOT ABSENT) for prevention of hyperglycemia but sufficient insulin for suppression of lipolysis and ketogenesis.
Absence of significant acidosis.
Often identifiable precipitating event (infection, MI).

30
Q

what is the management for T1 diabetes

A

Exogenous insulin (basal-bolus regime)
Self-monitoring of glucose
Structured education
Technology

31
Q

What is teh management of T2 diabetes

A
Diet
Oral medication
Structured education
May need insulin later
Remission / reversal
32
Q

What are complication associated with diabetes

A
Prevention diabetes-related complications and their risk factors:
Retinopathy			
Neuropathy				
Nephropathy				
Cardiovascular
33
Q

what things should you look for in a consult of T2DM

A

Glycaemia: HbA1c, glucose monitoring if on insulin, medication review
Weight assessment
Blood pressure
Dyslipidaemia: cholesterol profile
Screening for complications: foot check, retinal screening

34
Q

what dietary recommendations should be used for T2

A
Healthy eating or diet
Total calories control
Reduce calories as fat 
Reduce calories as refined carbohydrate
Increase calories as complex carbohydrate
Increase soluble fibre
Decrease sodium
35
Q

what are the facets of pathophysiology of T2 DM

A

Excess hepatic glucose production
Resistance to action of circulating insulin
Inadequate insulin production for extent of insulin resistance
Excess glucose in circulation

All these problems can we solved with weight loss

36
Q

what drugs are used to treat T2

A

1) Metformin –> reduce hepatic glucose production from excess haptic glucose production
2) Metformin + thiozolidnediones –> improve insulin sensitivity ( solves the problem of resistance to action of circulation insulin )

3) Sulphonylureas
DPP4-inhibitors
GLP-1 Agonists
–> Boost insulin secretion–> Inadequate insulin production for extent of insulin resistance

4) Alpha glucosidase inhibitor
SGLT-2 inhibitor –. Inhibit carbohydrate gut absorption
Inhibit renal glucose resorption –> solves the problem of excess glucose in circulation

37
Q

what is metformin used for and what are the side effects

A

Biguanide, insulin sensitiser
First line if dietary / lifestyle adjustment has made no difference
Reduces insulin resistance
Reduced hepatic glucose output
Increases peripheral glucose disposal
GI side effects
Contraindicated in severe liver, severe cardiac or moderate renal failure

38
Q

what is the mechanism of sulphonylureas

A

Normal insulin release requires closer of the
ATP-sensitive potassium channel
Sulphonylureas eg gliclazide, bind to the ATP-sensitive potassium channel and close it, independent of glucose / ATP

39
Q

what is the mechanism of action of pioglitazone

A

Peroxisome proliferator-actived receptor agonists PPAR-γ
Pioglitazone
Insulin sensitizer, mainly peripheral
Adipocyte differentiation modified, weight gain but peripheral not central
Improvement in glycaemia and lipids
Evidence base on vascular outcomes
Side effects of older types hepatitis, heart failure

40
Q

what are side effects of glucose lowering therapies

A

Mild weight gain

41
Q

what is Glucagon like peptide - 1 ( GLP-1) and what is it’s function

A

Gut hormone
Secreted in response to nutrients in gut
Transcription product of pro-glucagon gene, mostly from L-cell
Stimulates insulin, suppresses glucagon
↑ satiety (feeling of ‘fullness’)
Short half life due to rapid degradation from enzyme dipeptidyl peptidase-4 (DPP4 inhibitor)
Used in treatment of diabetes mellitus

42
Q

what are GLP-1 agonists

how are they administered and what is thier function

A
Liraglutide, Semaglutide
Injectable –daily, weekly
Decrease [glucagon]
Decrease [glucose]
Weight loss
43
Q

what are DDPG-4 inhibitors
agonists
how are they administered and what is thier function

A
Increase half life of exogenous GLP-1
Increase [GLP-1]
Decrease [glucagon]
Decrease [glucose]
Neutral on weight
44
Q

what are SGLT -2 inhibitors
agonists
how are they administered and what is thier function

A

Inhibits Na-Glu transporter, increases glycosuria
Empagliflozin, dapagliflozin, canagliflozin
HbA1c lower
32% lower all cause mortality
35% lower risk heart failure
Improve CKD

45
Q

What can improve remission of T2DM

A

Gastric bypass surgery has the potential to induce remission of type 2 diabetes

DIRECT Study / DROPLET study: very low-calorie diet (800 kcal/day) for 3-6 months has the potential to induce remission, which appears to be sustained at 2 years

Pilot NHS England remission programme

46
Q

what are aspects that need to be measured and treated with T2

A

Blood Pressure management
Hypertension very common in T2DM
Clear benefits for reduction esp with use of ACE-inhibitors

Lipid management
Total cholesterol raised
Triglycerides raised
HDL cholesterol reduced
Clear benefit to lipid-lowering therapy
47
Q

Extra

A

Extra

48
Q

Extra

A

Extra

49
Q

Extra

A

Extra

50
Q

Extra

A

Extra

51
Q

Extra

A

Extra

52
Q

Extra

A

Extra

53
Q

Extra

A

Extra

54
Q

Extra

A

Extra